切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (05) : 609 -611. doi: 10.3877/cma.j.issn.1674-6902.2019.05.015

短篇论著

非小细胞肺癌并发糖尿病患者uPA异常表达的影响因素分析
孔冉冉1, 马跃峰1, 马震川1, 孙良章1, 张丹杰1, 李少民1, 姜建涛1,()   
  1. 1. 710004 西安,西安交通大学第二附属医院胸外科
  • 收稿日期:2019-03-21 出版日期:2019-10-20
  • 通信作者: 姜建涛
  • 基金资助:
    陕西省重点研发计划项目资助(2017SF-130)

Influence factors of abnormal uPA expression in patients with non­small cell lung cancer complicated with diabetes

Ranran Kong1, Yuefeng Ma1, Zhenchuan Ma1   

  • Received:2019-03-21 Published:2019-10-20
引用本文:

孔冉冉, 马跃峰, 马震川, 孙良章, 张丹杰, 李少民, 姜建涛. 非小细胞肺癌并发糖尿病患者uPA异常表达的影响因素分析[J]. 中华肺部疾病杂志(电子版), 2019, 12(05): 609-611.

Ranran Kong, Yuefeng Ma, Zhenchuan Ma. Influence factors of abnormal uPA expression in patients with non­small cell lung cancer complicated with diabetes[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(05): 609-611.

表1 阳性组与阴性组临床资料比较[n(%)]
表2 影响NSCLC并发糖尿病患者uPA异常表达的多因素回归分析结果
1
Tong Y, Yue J, Mao M, et al. Recombinant nematode anticoagulant protein c2 inhibits cell invasion by decreasing uPA expression in NSCLC cells[J]. Oncology reports, 2015, 33(4): 1815-1822.
2
乐胜兵,吴密璐. 非小细胞肺癌靶向治疗研究进展[J]. 现代肿瘤医学,2016, 24(5): 840-843.
3
Della Corte CM, Ciaramella V, Di Mauro C, et al. Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells[J]. Oncotarget, 2016, 7(4): 4265.
4
Shen Z, Chen B, Gan X, et al. Methylation of neurofilament light polypeptide promoter is associated with cell invasion and metastasis in NSCLC[J]. Biochem Biophys Res Communicat, 2016, 470(3): 627-634.
5
贾晓琼,孙秋颖,温珍平. TFPT在非小细胞肺癌中的表达和意义[J]. 中国医师进修杂志,2018, 41(2): 149-152.
6
Li Z, Guo C, Liu X, et al. TIPE2 suppresses angiogenesis and non-small cell lung cancer (NSCLC) invasiveness via inhibiting Rac1 activation and VEGF expression[J]. Oncotarget, 2016, 7(38): 62224.
7
de Aberasturi A L, Redrado M, Villalba M, et al. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients[J]. Cancer Letters, 2016, 370(2): 165-176.
8
Liu K, Xu SH, Chen Z, et al. TRPM7 overexpression enhances the cancer stem cell-like and metastatic phenotypes of lung cancer through modulation of the Hsp90α/uPA/MMP2 signaling pathway[J]. BMC Cancer, 2018, 18(1): 1167.
9
杨 宏,韩 震,何 敏,等. 非小细胞肺癌EGFR突变与临床特性的相关性分析[J]. 内蒙古医科大学学报,2017, 39(4): 341-345.
10
高 歌,邓立力. 非小细胞肺癌EGFR、KRAS、ALK基因突变与不同转移器官分布的相关性研究进展[J]. 中国肺癌杂志,2018, 21(7): 536-542.
11
Rajasinghe LD, Hutchings M, Gupta SV. Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach[J]. Metabolites, 2019, 9(3): 50.
12
Van Der Steen N, Pauwels P, Gil-Bazo I, et al. cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance[J]. Cancers, 2015, 7(2): 556-573.
13
王晓莉,葛晓松,刘彦魁,等. EGFR/ALK/ROS1三联检测在非小细胞肺癌中的临床意义[J]. 临床与实验病理学杂志,2018, 34(10): 77-79.
14
Banys-Paluchowski M, Witzel I, Aktas B, et al. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer[J]. Scientific Reports, 2019, 9(1): 2318.
15
王 嘉,吕艳超,许浩然,等. 非小细胞肺癌组织中AKT1、PDCD4蛋白表达变化及意义[J]. 山东医药,2016, 56(6): 16-18.
16
Lu J J, Guo H, Gao B, et al. Prognostic value of urokinase plasminogen activator system in non-small cell lung cancer: A systematic review and meta-analysis[J]. Molecular Clin Oncol, 2018, 8(1): 127-132.
17
熊 娟,朱 静,张毅敏,等. Treg MMP-9及UPA mRNA在肺癌中的表达及临床意义[J]. 浙江临床医学,2017, 19(5): 798-800.
18
Hsia TC, Yu CC, Hsiao YT, et al. Cantharidin impairs cell migration and invasion of human lung cancer NCI-H460 cells via UPA and MAPK signaling pathways[J]. Anticancer Res, 2016, 36(11): 5989-5997.
19
Ostheimer C, Evers C, Bache M, et al. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume[J]. Strahlenth Onkolog, 2018, 194(6): 539-551.
20
Zhang H, Peng C, Huang H, et al. Effects of amiloride on physiological activity of stem cells of human lung cancer and possible mechanism[J]. Biochem Biophys Res Communicat, 2018, 504(1): 1-5.
21
Chang JH, Lai SL, Chen WS, et al. Quercetin suppresses the metastatic ability of lung cancer through inhibiting snail-dependent Akt activation and snail-independent ADAM9 expression pathways[J]. Biochem Biophys Acta (BBA)-Molecular Cell Res, 2017, 1864(10): 1746-1758.
22
Pavón MA, Arroyo-Solera I, Céspedes MV, et al. uPA/uPAR and SERPINE1 in head and neck cancer: role in tumor resistance, metastasis, prognosis and therapy[J]. Oncotarget, 2016, 7(35): 57351.
23
Banys-Paluchowski M, Witzel I, Aktas B, et al. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer[J]. Sci Rep, 2019, 9(1): 2318.
24
王学谦,林洪生. uPA/uPAR与恶性肿瘤关系的研究进展[J]. 医学研究杂志,2016, 45(9): 14-17.
25
赵文斌,范睿睿,马天宇. 血清CA125和HE4联合uPA及其受体在卵巢肿瘤中的表达和意义[J]. 中国慢性病预防与控制,2017, 25(25): 849.
26
Peng X, Zhou D, Wang X, et al. Matrine suppresses proliferation and invasion of SGC7901 cells through inactivation of PI3K/Akt/uPA pathway[J]. Ann Clin Lab Sci, 2016, 46(5): 457-462.
27
Woo JK, Jung HJ, Park JY, et al. Daurinol blocks breast and lung cancer metastasis and development by inhibition of focal adhesion kinase (FAK)[J]. Oncotarget, 2017, 8(34): 57058.
28
Wu JY, Lin SS, Hsu FT, et al. Fluoxetine inhibits DNA repair and NF-κB-modulated metastatic potential in non-small cell lung cancer[J]. Ant Res, 2018, 38(9): 5201-5210.
29
Wu M H, Chiu Y F, Wu W J, et al. Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression[J]. Environment Toxicol, 2018, 33(12): 1237-1244.
30
Hosseini N, Khoshnazar A, Saidijam M, et al. Zerumbone Suppresses Human Colorectal Cancer Invasion and Metastasis via Modulation of FAk/PI3k/NFκB-uPA Pathway[J]. Nutrit Cancer, 2019, 71(1): 159-171.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[3] 别瑶, 曹志斌, 辛静, 王健楠, 惠宗光. 应用基质血管成分细胞治疗糖尿病足溃疡的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(05): 453-456.
[4] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[5] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[6] 赵蒙蒙, 黄洁, 余荣环, 王葆青. 过表达小GTP酶Rab32抑制非小细胞肺癌细胞侵袭性生长[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 512-518.
[7] 张桂萍, 丘勇林, 湛绮婷, 孙乐栋. 晚期非小细胞肺癌血清Ape1/Ref-1对放射性肺损伤发生的预测意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 519-523.
[8] 韩晓宇, 李柯育, 赵志菲, 高建平. SNHG17过表达对非小细胞肺癌切除术预后的意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 543-547.
[9] 刘松, 张进召, 贾艳云. 帕博利珠单抗治疗晚期非小细胞肺癌反应降低与抗生素预处理的关系[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 553-557.
[10] 李多, 郝昭昭, 陈延伟, 南岩东. 血清PTX3表达与非小细胞肺癌骨转移的相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 558-562.
[11] 孙顗淼, 张颖. 糖尿病患者急性脑梗死取栓术后发生对比剂肾病的影响因素及预测模型建立[J]. 中华肾病研究电子杂志, 2024, 13(04): 188-194.
[12] 邱岭, 朱旭丽, 浦坚, 邢苗苗, 吴佳玲. 糖尿病肾病患者肠道菌群生态特点与胃肠道功能障碍的关联性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 453-458.
[13] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[14] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[15] 李玺, 蔡芸莹, 张永红, 苏恒. 假性软骨发育不全合并1型糖尿病一例[J]. 中华临床医师杂志(电子版), 2024, 18(05): 518-520.
阅读次数
全文


摘要